[In vivo antitumor activity of 5-hydroxy 3,4-dihydro naphthalene 1,8-carbolactone and its derivatives].
Berlion
M
M
Laboratoire de Physiologie et Pharmacologie I, Faculté de Pharmacie de Grenoble.
Riondel
J
J
Beriel
H
H
Rougny
A
A
Laharotte
C
C
Fillion
H
H
D000230:Adenocarcinoma / Q000473:pathology; D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D002286:Carcinoma, Ehrlich Tumor / Q000473:pathology; D008325:Mammary Neoplasms, Experimental / Q000473:pathology; D051379:Mice; D009284:Naphthols / Q000138:chemical synthesis* / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects*
D000970:Antineoplastic Agents; D009284:Naphthols; C058527:5-hydroxy-3,4-dihydronaphthalene-1,8-carbolactone
Activité antitumorale in vivo de l'hydroxy-5, dihydro-3,4 naphtalène carbolactone-1,8 et de ses dérivés.